Procedures designed to prevent microbiological contamination of drug products purporting to be sterile did not include adequate validation of the aseptic process.
Inspection Record
Merck Teknika LLC — FDA 483 Findings
Inspectors Brentley S Pittman · Lizaida PerezThe inspectors who signed the published document.Inspector lookup
View the regulator's official source The source document is always the basis for judgement.
Findings
Equipment used in the manufacture, processing, packing or holding of drug products is not of appropriate design to facilitate operations for its intended use.
Equipment and utensils are not maintained at appropriate intervals to prevent contamination that would alter the safety, identity, strength, quality or purity of the drug product.
The responsibilities and procedures applicable to the quality control unit are not fully followed.
Procedures designed to prevent microbiological contamination of drug products purporting to be sterile are not established and followed.
There is a failure to thoroughly review any unexplained discrepancy whether or not the batch has been already distributed.
Similar findings at other companies
GRM selected findings from the same type of public document whose wording is close to a finding in this document. One per company.
- Paxeuticals LLC2026-04-20 · US FDASimilar to finding 2 Equipment used in the manufacture, processing, packing or holding of drug products is not of appropriate design to facilitate operations for its intended use.
- Instituto Grifols, S.A.2023-11-17 · US FDASimilar to finding 6 There is a failure to thoroughly review any unexplained discrepancy whether or not the batch has been already distributed.
- Bello Bio LLC2025-12-16 · US FDASimilar to finding 1 Procedures designed to prevent microbiological contamination of drug products purporting to be sterile did not include validation of the aseptic process.
- Baxter Healthcare Corporation2025-11-25 · US FDASimilar to finding 4 The responsibilities and procedures applicable to the quality control unit are not fully followed.
- Wells Pharma of Houston LLC2026-04-13 · US FDASimilar to finding 4 The responsibilities and procedures applicable to the quality control unit are not fully followed.
A record as of the US FDA document published on 2026-10-27. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.